Antipsoriatic activity of 10-acyl analogues of dithranol (anthralin). II. Clinical comparison of dithranol and butantrone sticks with special reference to side effects. 1987

H Brandt

Thirty outpatients with limited (under 15% of skin area affected), symmetrical psoriasis of the plaque type were included in an open, right-left comparison study. Paraffin-based, 3% dithranol sticks (Ditrastick, Orion Pharmaceutica, Espoo, Finland) and similar, equimolar 4% butantrone sticks were used. Antipsoriatic activity, staining of the skin and clothes and irritation were the parameters followed up. An overall evaluation was made at the end of the trial. The antipsoriatic activity of dithranol and butantrone was almost equal at equimolar concentrations. Staining of the skin was significantly (at least p less than 0.05) milder with butantrone after 2 to 10 weeks treatment. Staining of clothes was less on the butantrone side for up to three months of use but was thereafter similar to that of dithranol. Irritation caused by butantrone reached its maximum only after 6 to 10 weeks and remained on average below the level of initial dithranol irritation. Six patients discontinued the treatment due to irritation by both preparations. Four patients tolerated better dithranol than butantrone. One patient could not use dithranol but cleared with butantrone. Thus, even if butantrone has an antipsoriatic efficacy almost equal to that of dithranol and is less staining than dithranol, it causes in some patients slowly increasing irritation with Koebner-like deterioration of the disease after some weeks of uneventful overnight use.

UI MeSH Term Description Entries
D007509 Irritants Drugs that act locally on cutaneous or mucosal surfaces to produce inflammation; those that cause redness due to hyperemia are rubefacients; those that raise blisters are vesicants and those that penetrate sebaceous glands and cause abscesses are pustulants; tear gases and mustard gases are also irritants. Counterirritant,Counterirritants,Irritant,Pustulant,Pustulants,Rubefacient,Rubefacients,Vesicant,Vesicants
D008297 Male Males
D011565 Psoriasis A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis. Palmoplantaris Pustulosis,Pustular Psoriasis of Palms and Soles,Pustulosis Palmaris et Plantaris,Pustulosis of Palms and Soles,Psoriases
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000287 Administration, Topical The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example. Drug Administration, Topical,Administration, Topical Drug,Topical Administration,Topical Drug Administration,Administrations, Topical,Administrations, Topical Drug,Drug Administrations, Topical,Topical Administrations,Topical Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000875 Anthralin An anthracene derivative that disrupts function and structure of MITOCHONDRIA and is used for the treatment of DERMATOSES, especially PSORIASIS. It may cause FOLLICULITIS. 1,8-Dihydroxy-9-anthrone,Dithranol,1,8,9-Anthracenetriol,1,8-Dihydroxy-9(10H)-anthracenone,Anthraforte,Anthranol,Cignolin,Cygnoline,Dihydroxyanthranol,Dithrocream,Ditranol FNA,Lasan,Micanol,Psoradrate,Psoricrème,1,8 Dihydroxy 9 anthrone,FNA, Ditranol
D012880 Skin Pigmentation Coloration of the skin. Skin Color,Skin Tone,Color, Skin,Colors, Skin,Pigmentation, Skin,Pigmentations, Skin,Skin Colors,Skin Pigmentations,Skin Tones,Tone, Skin,Tones, Skin

Related Publications

H Brandt
August 1981, The British journal of dermatology,
H Brandt
October 1986, Archives of toxicology,
Copied contents to your clipboard!